[Form 4] DarioHealth Corp. Insider Trading Activity

Rhea-AI Filing Summary

Adam K. Stern, a director of DarioHealth Corp. (DRIO), reported a restricted stock award of 20,000 shares granted on 09/11/2025 at a $0 price. The award is scheduled to vest on the last day of the second-year anniversary after the grant date. Following the reported transaction and reflecting a 20-for-1 reverse stock split effected on August 28, 2025, the filing shows 29,717 shares beneficially owned directly and 6,146 shares beneficially owned indirectly through AKS Family Partners L.P. The filing also discloses indirect beneficial ownership of 123,763 Series-C preferred shares. The form is signed by Mr. Stern on 09/15/2025.

Positive

• Restricted award disclosed with clear vesting schedule, indicating alignment of director incentives with long-term shareholder value
• Timely and complete Form 4 filing signed by the reporting person on 09/15/2025
• Disclosure includes impact of 20-for-1 reverse split, clarifying post-split share counts

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine insider grant with multi-year vesting aligns director incentives but does not signal immediate change in control or strategy.

The reported grant of 20,000 restricted common shares at $0 with a vesting date two years after grant is a common form of long-term compensation for directors intended to align interests with shareholders. The filing discloses both direct and indirect holdings and notes the recent 20-for-1 reverse split, which explains the presented share counts. There is no indication in the filing of accelerated vesting, option exercise, or disposal activity that would materially change governance dynamics. Disclosure appears timely and complete for a single reporting person Form 4.

Securities Analyst

TL;DR: Non-cash restricted award increases reported insider ownership but is a routine disclosure without immediate market impact.

The 20,000-share restricted award recorded at a $0 price increases Mr. Stern's direct reported holdings to 29,717 shares after the companys 20-for-1 reverse split. The filing also confirms indirect positions: 6,146 common shares and 123,763 Series-C preferred shares held via AKS Family Partners L.P. Because the grant vests over two years, the award represents a retention incentive rather than immediate liquidity or sale. There is no derivative activity reported and no sales or transfers disclosed that would signal near-term insider divestiture.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

STERN ADAM K

(Last) (First) (Middle)

322 W 57TH STREET, #33B

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025(1)		A		20,000	A	$0	29,717(2)	D
Common Stock								6,146(2)	I	By AKS Family Partners L.P.
Series-C Preferred Stock								123,763	I	By AKS Family Partners L.P.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted share award shall vest on the last day of the second-year anniversary after the grant date.

2. The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.

	/s/ Adam Stern	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Adam K. Stern report for DarioHealth (DRIO)?

He reported a restricted stock award of 20,000 common shares granted on 09/11/2025 at a price of $0.

When will the restricted shares reported by Adam K. Stern vest?

The restricted share award is scheduled to vest on the last day of the second-year anniversary after the grant date.

How many DarioHealth shares does Adam K. Stern beneficially own after the reported transaction?

The filing shows 29,717 shares beneficially owned directly after the transaction and 6,146 shares beneficially owned indirectly through AKS Family Partners L.P., reflecting the 20-for-1 reverse split.

Does the Form 4 report any derivative transactions by Adam K. Stern?

No. The filing contains no reported derivative securities transactions; it only reports a restricted common stock award and indirect preferred holdings.

What preferred holdings are disclosed for Adam K. Stern?

The Form 4 discloses indirect beneficial ownership of 123,763 Series-C preferred shares held by AKS Family Partners L.P.